SEC Form 4 · accession 0001437749-17-005029
VIVEVE MEDICAL, INC. · VIVE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Janney
Director
Period of report
Mar 17, 2017
Accepted (ET)
Mar 21, 2017 · 6:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000879682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Mar 17, 2017 | P | 500,000 | $4.00 | A | 1,381,955 | I | See Footnotes |
| Common Stock | holding | — | — | — | 3,054 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Directly beneficially owned by Alta Bioequities, L.P.
- F2Alta Bioequities Management, LLC is the general partner of Alta Bioequities, L.P. and may be deemed to have sole voting and investment power over the shares beneficially owned by Alta Bioequities, L.P. Daniel Janney is the Managing Director of Alta Bioequities Management, LLC. Mr. Janney disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.